Warfarin Versus Aspirin Recurrent Stroke Study

• Status: Completed
• Trial end date: 2001-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The goal of this study is to compare aspirin to warfarin for the prevention of recurrent stroke.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Columbia University
• Collaborator: National Institute of Neurological Disorders and Stroke (NINDS)
• Treatments: Aspirin; Warfarin

Criteria

Inclusion:

• Acceptable candidates for warfarin therapy

• Had an ischemic stroke within the previous 30 days

• Had scores of 3 or more on the Glasgow Outcome Scale

Exclusion:

• Base-line INR above the normal range (more than 1.4)

• History of stroke due to a procedure or that was attributed to high-grade carotid stenosis for which surgery was planned

• History of stroke associated with an inferred cardioembolic source